Patents by Inventor Roland Levin

Roland Levin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11839709
    Abstract: A dialysis system is provided that includes a dialysis machine and a potassium sensing device that is configured to measure the concentration of potassium in the patient's blood, in spent dialysate resulting from treating the patient, or in both. The potassium sensing device can be configured to generate a sensed value of the concentration of potassium. A control and computing unit, including a processor and a memory, is configured to receive the sensed value, compare the value with one or more values stored in the memory, and generate a control signal based on the comparison. A potassium infusion circuit uses the control signal to infuse supplemental potassium solution into the treatment dialysate, a replacement fluid, or both. The memory can include stored patient-historical and population data.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: December 12, 2023
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Publication number: 20230395245
    Abstract: Medical devices and peripheral devices can be configured to wirelessly communicate with each other and other devices through a connection between the devices. Peripheral devices may include weight scales, blood pressure monitors and/or other medical components that may be used in connection with measuring patient information related to a medical treatment by a medical device, such as a dialysis treatment performed by a dialysis machine. A medical function/data transfer device according to the system described herein may include multi-function capabilities to provide for a medical monitoring or treatment function as well as a data transfer function for transferring data between interconnected medical devices.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 7, 2023
    Inventors: David Yuds, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20230293792
    Abstract: A dialysis system (e.g., a hemodialysis (HD) system) can be designed to operate in alternative environments, such as disaster relief settings or underdeveloped regions. The dialysis system can include a solar panel for generating electricity to power the dialysis machine and an atmospheric water generator for extracting water from ambient air. The extracted water can be used to generate dialysate and saline on-site. One or more of the components of the dialysis machine can be discrete components that are configured to facilitate fast shipping and simple on-site assembly (e.g., at a remote location). In some implementations, the discrete components may be configured to be attached to an existing dialysis system (e.g., a dialysis system designed for operation in a traditional environment) to permit the dialysis system to operate in an alternative environment.
    Type: Application
    Filed: May 30, 2023
    Publication date: September 21, 2023
    Inventors: Roger Caluya, Martin Joseph Crnkovich, Bert D. Egley, David Charles Griffith, Jr., Roland Levin, Houssein Nasseri, Kulwinder S. Plahey, David Yuds
  • Patent number: 11738125
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: August 29, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Patent number: 11701456
    Abstract: A dialysis system (e.g., a hemodialysis (HD) system) can be designed to operate in alternative environments, such as disaster relief settings or underdeveloped regions. The dialysis system can include a solar panel for generating electricity to power the dialysis machine and an atmospheric water generator for extracting water from ambient air. The extracted water can be used to generate dialysate and saline on-site. One or more of the components of the dialysis machine can be discrete components that are configured to facilitate fast shipping and simple on-site assembly (e.g., at a remote location). In some implementations, the discrete components may be configured to be attached to an existing dialysis system (e.g., a dialysis system designed for operation in a traditional environment) to permit the dialysis system to operate in an alternative environment.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: July 18, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Roger Caluya, Martin Joseph Crnkovich, Bert D. Egley, David Charles Griffith, Jr., Roland Levin, Houssein Nasseri, Kulwinder S. Plahey, David Yuds
  • Patent number: 11590454
    Abstract: A leak may be detected in a heat exchanger of a hemodialysis device. A drain valve is opened by the controller, and then closed by the controller after a pre-selected time period. An initial pressure is determined in the spent dialysate circuit and stored in the memory. A system pressure is determined at periodic time intervals and compared to a pre-determined maximum pressure. The controller then determines whether the heat exchanger has a leak, in that in response to the system pressure exceeding a predetermined maximum pressure, a command is generated to execute an event including suspending a disinfectant operation with a disinfecting agent, and in response to the initial pressure subtracted from the system pressure being greater than a predetermined minimum pressure differential, a command is generated to execute an event including suspending the cleanse operation with the disinfecting agent.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: February 28, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Martin Crnkovich, Roland Levin, Christopher McCormick, Fei Wang, Aiyuan Wang
  • Patent number: 11577012
    Abstract: A blood treatment machine includes a patient comfort feedback mechanism configured to be adjusted by a patient to indicate comfort levels of the patient. The machine is configured to adjust one or more treatment parameters based on the patient feedback.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: February 14, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: David Yuds, Eric Bergman, Ken Chhi, Stephen Merchant, Christopher Yim Chau, Roland Levin
  • Patent number: 11524102
    Abstract: A dialysis system is provided that includes a dialysis machine and a potassium sensing device that is configured to measure the concentration of potassium in the patient's blood, in spent dialysate resulting from treating the patient, or in both. The potassium sensing device can be configured to generate a sensed value of the concentration of potassium. A control and computing unit, including a processor and a memory, is configured to receive the sensed value, compare the value with one or more values stored in the memory, and generate a control signal based on the comparison. A potassium infusion circuit uses the control signal to infuse supplemental potassium solution into the treatment dialysate, a replacement fluid, or both. The memory can include stored patient-historical and population data.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: December 13, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Patent number: 11491267
    Abstract: A method of dialysis is provided that includes sensing the concentration of potassium in a patient's blood serum, in used dialysate resulting from treating the patient, or in both. The method involves generating a sensed value of the concentration of potassium, comparing the sensed value with one or more values stored in a memory, and generating a control signal based on the comparison. Supplemental potassium solution is infused into the treatment dialysate, based on the control signal. The comparison can be made to patient-historical data, population data, or both.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: November 8, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Publication number: 20210338908
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: May 14, 2021
    Publication date: November 4, 2021
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Patent number: 11062806
    Abstract: In general, a dialysis device includes a first processing device for monitoring dialysis functions of the dialysis device, a second processing device, a display device, and memory. The memory is configured to store instructions that, when executed, cause the dialysis device to provide, on the display device, a first display region and a second display region, where the first display region is associated with the first processing device and the second display region is associated with the second processing device. At least a portion of the first display region cannot be obscured by the second display region.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: July 13, 2021
    Assignee: Fresenius Medical Care Holdings, Ino.
    Inventors: Fei Wang, Martin Joseph Crnkovich, Roland Levin, Michael Emmanuel Kotsos
  • Patent number: 11007310
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: May 18, 2021
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20200368418
    Abstract: A blood treatment machine includes a patient comfort feedback mechanism configured to be adjusted by a patient to indicate comfort levels of the patient. The machine is configured to adjust one or more treatment parameters based on the patient feedback.
    Type: Application
    Filed: May 21, 2019
    Publication date: November 26, 2020
    Inventors: David Yuds, Eric Bergman, Ken Chhi, Stephen Merchant, Christopher Yim Chau, Roland Levin
  • Publication number: 20200222611
    Abstract: A dialysis system (e.g., a hemodialysis (HD) system) can be designed to operate in alternative environments, such as disaster relief settings or underdeveloped regions. The dialysis system can include a solar panel for generating electricity to power the dialysis machine and an atmospheric water generator for extracting water from ambient air. The extracted water can be used to generate dialysate and saline on-site. One or more of the components of the dialysis machine can be discrete components that are configured to facilitate fast shipping and simple on-site assembly (e.g., at a remote location). In some implementations, the discrete components may be configured to be attached to an existing dialysis system (e.g., a dialysis system designed for operation in a traditional environment) to permit the dialysis system to operate in an alternative environment.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 16, 2020
    Inventors: Roger Caluya, Martin Joseph Crnkovich, Bert D. Egley, David Charles Griffith, Roland Levin, Houssein Nasseri, Kulwinder S. Plahey, David Yuds
  • Publication number: 20200206403
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: December 28, 2018
    Publication date: July 2, 2020
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Patent number: 10632242
    Abstract: A dialysis system (e.g., a hemodialysis (HD) system) can be designed to operate in alternative environments, such as disaster relief settings or underdeveloped regions. The dialysis system can include a solar panel for generating electricity to power the dialysis machine and an atmospheric water generator for extracting water from ambient air. The extracted water can be used to generate dialysate and saline on-site. One or more of the components of the dialysis machine can be discrete components that are configured to facilitate fast shipping and simple on-site assembly (e.g., at a remote location). In some implementations, the discrete components may be configured to be attached to an existing dialysis system (e.g., a dialysis system designed for operation in a traditional environment) to permit the dialysis system to operate in an alternative environment.
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: April 28, 2020
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Roger Caluya, Martin Joseph Crnkovich, Bert D. Egley, David Charles Griffith, Jr., Roland Levin, Houssein Nasseri, Kulwinder S. Plahey, David Yuds
  • Publication number: 20200030515
    Abstract: A method of dialysis is provided that includes sensing the concentration of potassium in a patient's blood serum, in used dialysate resulting from treating the patient, or in both. The method involves generating a sensed value of the concentration of potassium, comparing the sensed value with one or more values stored in a memory, and generating a control signal based on the comparison. Supplemental potassium solution is infused into the treatment dialysate, based on the control signal. The comparison can be made to patient-historical data, population data, or both.
    Type: Application
    Filed: July 24, 2019
    Publication date: January 30, 2020
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Publication number: 20200030514
    Abstract: A dialysis system is provided that includes a dialysis machine and a potassium sensing device that is configured to measure the concentration of potassium in the patient's blood, in spent dialysate resulting from treating the patient, or in both. The potassium sensing device can be configured to generate a sensed value of the concentration of potassium. A control and computing unit, including a processor and a memory, is configured to receive the sensed value, compare the value with one or more values stored in the memory, and generate a control signal based on the comparison. A potassium infusion circuit uses the control signal to infuse supplemental potassium solution into the treatment dialysate, a replacement fluid, or both. The memory can include stored patient-historical and population data.
    Type: Application
    Filed: July 24, 2019
    Publication date: January 30, 2020
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Publication number: 20200030513
    Abstract: In general, a dialysis device includes a first processing device for monitoring dialysis functions of the dialysis device, a second processing device, a display device, and memory. The memory is configured to store instructions that, when executed, cause the dialysis device to provide, on the display device, a first display region and a second display region, where the first display region is associated with the first processing device and the second display region is associated with the second processing device. At least a portion of the first display region cannot be obscured by the second display region.
    Type: Application
    Filed: October 3, 2019
    Publication date: January 30, 2020
    Inventors: Fei Wang, Martin Joseph Crnkovich, Roland Levin, Michael Emmanuel Kotsos
  • Patent number: 10518015
    Abstract: A hemodialysis machine includes a main body and a door connected to the main body. The door and the main body cooperate to define a non-removable chamber. The door is openable relative to the main body of the hemodialysis machine to allow a salt to be placed into the non-removable chamber when the door is in an open position. The main body further includes a fluid inlet, a fluid outlet, and a pumping mechanism. The fluid inlet and the fluid outlet are in fluid communication with the non-removable chamber. The pumping mechanism is configured to deliver a fluid from a fluid source to the non-removable chamber through the fluid inlet to mix with salt within the non-removable chamber to form a salt solution that exits the non-removable chamber through the fluid outlet.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: December 31, 2019
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: James Concepcion, Robert E. Hassard, Christopher McCormick, Roland Levin